Drug Use Was High During Early COVID-19 Pandemic miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Seven in 10 adults with opioid use disorder who receive prescriptions for buprenorphine to help combat addiction take their medication as directed and don’t misuse it, a U.S. study finds.
Depot Buprenorphine a Shot in the Arm for Opioid Addiction? medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
May 12, 2021
Patients report greater satisfaction with weekly, monthly buprenorphine
People with opioid dependence reported being more satisfied and more compliant with weekly or monthly depot buprenorphine versus sublingual buprenorphine, researchers reported.
In an open-label, 24-week randomized trial done at six outpatient clinical sites in Australia, the self-reported global satisfaction score was significantly higher for the depot group compared with the sublingual group at a mean TSQM (Treatment Satisfaction Questionnaire for Medication v1.4) score of 82.5 versus 74.3, for a difference of 8.2 (95% CI 1.7-14.6,
P=0.01), according to Fredrik Tiberg, PhD, of Camurus in Lund, Sweden, and co-authors (TQSM ranges from 0-100 with higher score indicating greater satisfaction).